ANTHROPIC SAYS IT HAS ACQUIRED MITHRIL MEDICINE TO RUN RARE DISEASE PROGRAMS, ADDING THAT IT WANTS TO SHARE ITS MODELS WITH DRUG DEVELOPMENT RESEARCHERS AND AS MANY RESEARCHERS AS POSSIBLE, AND THAT IT LOOKS FORWARD TO WORKING WITH MORE ORGANIZATIONS 27-OCT-2026 04:34 PM ET